From: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer
Group
n
MMP9 mRNA
DMSO
10
1.320 ± 0.0524
CoCl2
0.881 ± 0.0723
glibenclamide
0.941 ± 0.0948
F = 447.86 P = 0.021
CoCl2 + glibenclamide
0.481 ± 0.0685
paclitaxel
0.424 ± 0.0517